Prospectively Randomized Phase III Trial, Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast Cancer

Trial Profile

Prospectively Randomized Phase III Trial, Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast Cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Nov 2015

At a glance

  • Drugs Docetaxel (Primary) ; Gemcitabine (Primary) ; Cyclophosphamide; Epirubicin; Fluorouracil; Goserelin; Letrozole; Tamoxifen
  • Indications Early breast cancer
  • Focus Therapeutic Use
  • Acronyms SUCCESS-B
  • Most Recent Events

    • 06 Jun 2012 New source identified and integrated (German Clinical Trials Register, DRKS00003641).
    • 02 Apr 2012 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
    • 02 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top